The positive correlation between PYGB and TNFSF4 (also known as OX40L), a co-stimulatory molecule that enhances T-cell activation and survival, suggested its potential role in modulating T-cell responses and promoting anti-tumor immunity (60). The gene discussed is PYGB; the disease is neoplasm.